株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
企業レポート

前立腺癌:現在・将来の市場参入企業

Prostate Cancer - Current and Future Players

発行 GlobalData 商品コード 263601
出版日 ページ情報 英文 60 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
前立腺癌:現在・将来の市場参入企業 Prostate Cancer - Current and Future Players
出版日: 2015年04月08日 ページ情報: 英文 60 Pages
概要

当レポートでは、世界の前立腺癌関連市場における既存企業および新規参入企業について分析し、市場全体の将来展望や促進・抑制要因、現在・将来の競争動向、主要企業のプロファイル(企業概要、事業展開、財務状況、SWOT分析)、市場全体と各企業の将来展望などを調査・考察しています。

第1章 目次

第2章 イントロダクション

第3章 市場の見通し

  • 世界市場
    • 予測
    • 促進・阻害要因:世界市場の課題

第4章 現在・将来の市場参入企業

  • 概要
  • 企業戦略の傾向
  • 企業プロファイル
    • アステラス
    • Johnson & Johnson
    • Bayer

第5章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1060FPR

GlobalData has released its pharma report, "Prostate Cancer - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prostate Cancer Market. The report identifies and analyses the key companies shaping and driving the global Prostate Cancer market. The report provides insight into the competitive Prostate Cancer landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Prostate Cancer
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Prostate Cancer sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving Prostate Cancer market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What's the next big thing in the global Prostate Cancer market landscape? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Market Outlook

  • 3.1. Global Markets
    • 3.1.1. Forecast
    • 3.1.2. Drivers and Barriers - Global Issues

4. Current and Future Players

  • 4.1. Overview
  • 4.2. Trends in Corporate Strategy
  • 4.3. Company Profiles
    • 4.3.1. Astellas
    • 4.3.2. Johnson & Johnson
    • 4.3.3. Bayer

5. Appendix

  • 5.1. Bibliography
  • 5.2. Abbreviations
  • 5.3. Methodology
  • 5.4. Forecasting Methodology
    • 5.4.1. Diagnosed Prostate Cancer Patients
    • 5.4.2. Percentage Drug-Treated Patients
    • 5.4.3. Drugs Included in Each Therapeutic Class
    • 5.4.4. Launch and Patent Expiry Dates
    • 5.4.5. General Pricing Assumptions
    • 5.4.6. Individual Drug Assumptions
    • 5.4.7. Pricing of Pipeline Agents
  • 5.5. Primary Research - KOLs Interviewed for This Report
  • 5.6. Primary Research - Prescriber Survey
  • 5.7. About the Authors
    • 5.7.1. Analyst
    • 5.7.2. Director of Oncology
    • 5.7.3. Epidemiologist
    • 5.7.4. Global Head of Healthcare
  • 5.8. About GlobalData
  • 5.9. Disclaimer

List of Tables

  • Table 1: Global Sales Forecasts ($m) for Prostate Cancer, 2013-2023
  • Table 2: Global Prostate Cancer Market - Drivers and Barriers, 2013-2023
  • Table 3: Key Companies in the Prostate Cancer Market in the 9MM, 2014
  • Table 4: Astellas' Prostate Cancer Portfolio Assessment, 2014
  • Table 5: J&J's Prostate Cancer Portfolio Assessment, 2014
  • Table 6: Bayer's Prostate Cancer Portfolio Assessment, 2014
  • Table 7: Key Launch Dates, Marketed and Pipeline Prostate Cancer Drugs
  • Table 8: Key Patent Expiration or Loss of Market Exclusivity Dates, Marketed Prostate Cancer Drugs
  • Table 9: Average Body Weight and Surface Area Across the 9MM
  • Table 10: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country

List of Figures

  • Figure 1: Global Sales for Prostate Cancer by Region, 2013-2023
  • Figure 2: Company Portfolio Gap Analysis in Prostate Cancer, 2013-2023
Back to Top